Skip to main content

Advertisement

Table 3 Changes in selected parameters in Control and RESMENA groups after 8 weeks of nutritional intervention

From: Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial

Variable Control group (n = 48) Resmena group (n = 48)  
Visit 1 (day 0) Visit 2 (day 60) p a Visit 1 (day 0) Visit 2 (day 60) p b p c
Weight (kg) 99.45 ± 19.21 92.72 ± 18.50 <0.001 100.00 ± 16.58 92.91 ± 15.76 <0.001 0.555
BMI (kg/m2) 36.15 ± 4.95 33.70 ± 4.80 <0.001 35.55 ± 4.40 33.03 ± 4.24 <0.001 0.732
Waist circumference (cm) 110.94 ± 13.41 104.18 ± 12.29 <0.001 111.25 ± 12.30 103.78 ± 11.66 <0.001 0.432
Waist/hip ratio 0.96 ± 0.10 0.94 ± 0.09 <0.001 0.96 ± 0.10 0.93 ± 0.10 <0.001 0.355
Bioimpedance Fat mass (kg) 38.97 ± 10.87 33.68 ± 10.22 <0.001 39.23 ± 9.50 33.84 ± 9.09 <0.001 0.886
DXA Fat mass (kg) 42.13 ± 10.18 37.50 ± 10.39 <0.001 42.56 ± 9.18 37.30 ± 8.95 <0.001 0.208
TC (mg/dl) 221 ± 39 204 ± 39 0.001 219 ± 48 203 ± 46 0.020 0.943
HDL-c (mg/dl) 46 ± 10 42 ± 9 0.001 43 ± 10 41 ± 10 0.050 0.158
LDL-c (mg/dl) 140 ± 36 133 ± 35 0.085 137 ± 41 131 ± 40 0.374 0.888
TC/HDL-c ratio 4.94 ± 1.02 4.96 ± 0.94 0.856 5.18 ± 1.24 5.04 ± 1.24 0.398 0.419
LDL-c/HDL-c ratio 3.09 ± 0.77 3.22 ± 0.78 0.178 3.20 ± 0.83 3.23 ± 0.92 0.803 0.623
TG (mg/dl) 176 ± 10 145 ± 70 0.005 194 ± 123 151 ± 99 <0.001 0.421
Glucose (mg/dl) 121.02 ± 33.87 107.98 ± 13.71 0.006 123.81 ± 37.82 110.22 ± 26.18 0.016 0.939
Insulin (IU/mg) 15.30 ± 11.46 9.32 ± 7.18 <0.001 14.36 ± 8.30 9.14 ± 6.13 <0.001 0.557
HOMA index 4.69 ± 3.77 2.61 ± 2.31 <0.001 4.48 ± 3.01 2.60 ± 2.00 <0.001 0.686
ALT (U/L) 37.60 ± 21.04 27.03 ± 10.70 <0.001 29.13 ± 11.59 29.28 ± 14.20 0.936 0.001
AST (U/L) 25.81 ± 10.84 20.68 ± 6.18 0.001 21.90 ± 6.01 22.20 ± 6.14 0.740 0.002
  1. BMI, Body Mass Index; DXA, Dual-energy X-ray Absorptiometry; HDL-c, High Density Lipoprotein-cholesterol; LDL-c, Low Density Lipoprotein-cholesterol; TG, Triglycerides; HOMA, Homeostasis Model Assessment; ALT, Alanine aminotransferase; AST, Aspartate aminotranferase. p < 0.05 was set-up as statistically significant.
  2. pa differences between baseline and final values in Control group. pb differences between baseline and final values in RESMENA group. pc differences between changes in Control group as compared with RESMENA group at the end of the intervention.